Cabergoline may act as a radioprotective agent in Cushing's disease
暂无分享,去创建一个
T. Gupta | A. Goel | A. Shah | R. Jalali | N. Shah | V. Sarathi | R. Krishnatry | K. Thakkar | Swati Ramteke-Jadhav | S. Memon | Virendra A. Patil | S. Sankhe | A. Lila | T. Bandgar | M. Goroshi
[1] John Y. K. Lee,et al. Technique of Whole-Sellar Stereotactic Radiosurgery for Cushing Disease: Results from a Multicenter, International Cohort Study. , 2018, World neurosurgery.
[2] Fares Alahdab,et al. PREDICTORS OF BIOCHEMICAL REMISSION AND RECURRENCE AFTER SURGICAL AND RADIATION TREATMENTS OF CUSHING DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[3] M. A. O. Ignacio,et al. How to cite this article , 2016 .
[4] A. Tabarin,et al. Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. , 2015, The Journal of clinical endocrinology and metabolism.
[5] M. Bronstein,et al. Ketoconazole Treatment Decreases the Viability of Immortalized Pituitary Cell Lines Associated with an Increased Expression of Apoptosis‐Related Genes and Cell Cycle Inhibitors , 2015, Journal of neuroendocrinology.
[6] A. Colao,et al. The Treatment of Cushing's Disease. , 2015, Endocrine reviews.
[7] P. Chanson,et al. Therapy of endocrine disease: outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence. , 2015, European journal of endocrinology.
[8] A. Gutierrez-Hartmann,et al. Signaling pathways regulating pituitary lactotrope homeostasis and tumorigenesis. , 2015, Advances in experimental medicine and biology.
[9] T. Gupta,et al. Encouraging efficacy of modern conformal fractionated radiotherapy in patients with uncured Cushing’s disease , 2014, Pituitary.
[10] Paul J. Schmitt,et al. Results of gamma knife surgery for Cushing's disease. , 2013, Journal of neurosurgery.
[11] N. Shah,et al. Efficacy of cabergoline in uncured (persistent or recurrent) Cushing disease after pituitary surgical treatment with or without radiotherapy. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[12] M. Bondanelli,et al. Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds. , 2007, European journal of endocrinology.
[13] V. Esposito,et al. Long-term follow-up results of postoperative radiation therapy for Cushing’s disease , 2007, Journal of Neuro-Oncology.
[14] J. Régis,et al. Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's disease. , 2007, European journal of endocrinology.
[15] A. Landolt,et al. Gamma knife radiosurgery for prolactinomas. , 2000, Journal of neurosurgery.
[16] S. Scheib,et al. Octreotide may act as a radioprotective agent in acromegaly. , 2000, The Journal of clinical endocrinology and metabolism.
[17] R. Magallón,et al. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease. , 1997, The New England journal of medicine.
[18] N. Yamakita,et al. Long term follow-up of Cushing's disease treated with reserpine and pituitary irradiation. , 1992, The Journal of clinical endocrinology and metabolism.
[19] M. Littley,et al. LONG‐TERM FOLLOW‐UP OF LOW‐DOSE EXTERNAL PITUITARY IRRADIATION FOR CUSHING'S DISEASE , 1990, Clinical endocrinology.